HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 34 filers reported holding HORIZON PHARMA INVT LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,593,000 | -11.5% | 5,603,000 | 0.0% | 0.23% | +10.4% |
| Q4 2019 | $7,448,000 | +13.8% | 5,603,000 | 0.0% | 0.21% | +5.5% |
| Q3 2019 | $6,546,000 | +5.4% | 5,603,000 | 0.0% | 0.20% | +4.2% |
| Q2 2019 | $6,212,000 | -2.3% | 5,603,000 | 0.0% | 0.19% | -5.9% |
| Q1 2019 | $6,356,000 | +13.6% | 5,603,000 | 0.0% | 0.20% | -0.5% |
| Q4 2018 | $5,595,000 | -11.6% | 5,603,000 | -10.8% | 0.20% | +17.1% |
| Q3 2018 | $6,332,000 | +5.0% | 6,278,000 | 0.0% | 0.18% | +0.6% |
| Q2 2018 | $6,031,000 | +4.2% | 6,278,000 | 0.0% | 0.17% | -11.2% |
| Q1 2018 | $5,788,000 | -0.8% | 6,278,000 | 0.0% | 0.20% | -1.0% |
| Q4 2017 | $5,835,000 | +2.6% | 6,278,000 | 0.0% | 0.20% | -2.0% |
| Q3 2017 | $5,686,000 | +4.7% | 6,278,000 | 0.0% | 0.20% | -1.0% |
| Q2 2017 | $5,430,000 | -5.8% | 6,278,000 | 0.0% | 0.20% | -7.7% |
| Q1 2017 | $5,766,000 | -3.7% | 6,278,000 | 0.0% | 0.22% | -1.8% |
| Q4 2016 | $5,989,000 | -2.0% | 6,278,000 | -0.1% | 0.22% | +3.7% |
| Q3 2016 | $6,114,000 | +4.5% | 6,284,000 | -2.0% | 0.22% | +2.4% |
| Q2 2016 | $5,851,000 | +27.0% | 6,412,000 | +18.7% | 0.21% | +40.4% |
| Q1 2016 | $4,606,000 | – | 5,403,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|